Wednesday, June 24, 2015

Health Research:Generic heart disease medications offer promise for Ebola treatment ♦ Potential treatment target identified for rare form of diabetes ♦ Researchers identify new class of antifungal agents

Study predicts variation in illness severity in a population When individual random quantities, such as reactions in the body, are instead correlated, and multiplied, the process gives rise to the ubiquitous, highly skewed pattern, and that this pattern is more accurately called a Weibull distribution.
Generic heart disease medications offer promise for Ebola treatment Generic medications used frequently in the management of heart disease patients also have the potential to bolster the immune systems of patients with Ebola virus and some other life-threatening illnesses.
Potential treatment target identified for rare form of diabetes, other disorders Scientists working to find treatments for a rare and severe form of diabetes known as Wolfram syndrome have identified a gatekeeper in cells that prevents harmful molecules from spilling and triggering cell death. The researchers also have found that the gatekeeper may be a good treatment target not only for diabetes but for heart problems, Parkinson’s disease and other disorders.
Researchers identify new class of antifungal agents A new class of antifungals has been identified, potentially useful to treat the more than 300 million people worldwide who develop serious fungal infections. Fungal infections are most commonly found in individuals with medical conditions that compromise the immune system, such as AIDS, or individuals who are being treated with immunosuppressives, such as those battling cancer..
Men think they are maths experts, therefore they are Just because more men pursue careers in science and engineering does not mean they are actually better at math than women are. The difference is that men think they are much better at math than they really are. Women, on the other hand, tend to accurately estimate their arithmetic prowess.

No comments:

Post a Comment